Identifies potential target companies in the technology sector. Conducts due diligence on potential target companies. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 118× for every dollar of annual revenue.
No analyst target is on record for this company.
Sales run at $53.4M a year. A small number, but proof the product has real buyers.
A loss of $929.8M against $53.4M in annual sales.
At the current pace of spending, the cash lasts about 1.5 years. After that, the company needs to find new money.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the price history.